Friday, 1 July, 2022
TopicPharma sector

Topic: Pharma sector

Modi govt plans action against US writer who said Indian drugs are ‘flea-market quality’

In her May 2019 book Bottle of Lies, Katherine Eban accused Indian pharma firms of major lapses such as ‘toxic impurities’ and fudging data on quality control.  

Indian drugmakers aren’t losing sleep despite getting a record 23 warnings from US FDA

American drug regulator FDA has issued warning letters to India’s top firms such as Lupin, Glenmark Pharmaceuticals, Torrent Pharmaceuticals, Aurobindo & Cadila.

Big Pharma has failed. It’s been 35 years since a new class of antibiotics entered the market

Antibiotics are among the most important medicines known to humankind, but we are running out of it.

Indians pay 70% less than the global median to buy medicines, study finds

A study compared the prices of drug compounds across the world and found that only Thailand, Kenya, Malaysia and Indonesia are cheaper than India.

Hundreds of colleges came up amid India’s pharma boom. Here’s why govt wants no more

India has barred new pharma colleges until 2021-22 to check poor-quality institutes looking to tap the industry’s growing popularity.

Major Indian drugmakers receive FDA warning over quality issues, tainted supplies

Cadila Healthcare, Glenmark Pharma and Lupin Ltd. are the latest medicine makers to be reprimanded by the US health care watchdog.

In a first, India’s Dr Reddy’s Labs to supply a generic drug to China’s public hospitals

Amid concerns about rising trade deficit between India and China, Dr Reddy’s has won a tender to supply Olanzapine, a drug used to treat mental ailments.

Indian pharma is not sub-par, it is ensuring the world doesn’t face a healthcare crisis

Katherine Eban's book 'Bottle of Lies', about the 2004 Ranbaxy scandal, paints whole of Indian pharma as being unreliable, which is dangerous & biased.

Swarms of bugs, missing data plague firms now making heart drug in India

Inspection reports by US federal agency FDA stated that workers destroyed records indicating that drugs were failing key quality measures.

India’s copycat drugs could do serious harm to patient health, says US pharma lobby

American pharma lobby slams India for not turning into reality the positive signs shown by the government about providing better market access.

On Camera


PM Modi at the MSME Idea Hackathon, 2022. | Praveen Jain | ThePrint

BJP, Modi’s ‘total politics’ stems from insecurity. They still don’t rule the power elite

Yogendra Yadav is wrong. BJP might have a hegemonic position in politics and economy, but it's not the same in moral and intellectual spaces.
The Reserve Bank of India logo | Photo: Suraj Singh Bisht | ThePrint

RBI intervenes with multi-pronged strategy in battle against rupee fall

The Reserve Bank’s challenges include crashes in forward dollar premiums to rising open interest in futures that adds to pressure on the currency.


National Security Adviser Ajit Doval | File photo: ANI

At 1st Maritime Security Group meet, NSA chief Doval stresses on coordination among stakeholders

Meeting chaired by Vice Admiral (retd) G. Ashok Kumar, India’s 1st national maritime security coordinator. ‘Crucial policy issues’ such as ‘blue economy initiative’ also discussed.

With Agnipath, Modi govt’s shock & awe doctrine may have misfired a vital reform, yet again

Modi govt's biggest flaw has been its disinclination to accept limitations of electoral majorities. This ruined land acquisition and farm reform, stalled labour codes.